AGP Executive Report
Last update: 6 hours agoClinical Advances: Roche reported phase III results showing its investigational lung cancer drug divarasib cut the risk of death by 44% versus older KRAS G12C inhibitors. A second trial found sefaxersen reduced proteinuria—a marker of kidney damage—by 43.1% in people with IgA nephropathy. Workforce: Nigeria says it has recruited more than 30,000 health professionals in two and a half years and is seeking to curb doctors’ migration abroad. Care Access: Encompass Health plans a 24-bed rehabilitation hospital near Houston, bringing specialized care closer to patients recovering from strokes, injuries and major illness. Cancer Awareness: A Stanford physician’s stage 4 lung cancer diagnosis despite never smoking highlights a growing concern: lung cancer in nonsmokers. Health Innovation: Nigerian startup Instant Rad won a $50,000 prize for its AI-enabled teleradiology platform, designed to connect hospitals and diagnostic centers with radiologists.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
